131, 6, 415-21.
[310] Shirey K.A., Lai W., Scott A.J., Lipsky M., Mistry P., Pletneva L.M., Karp C.L., McAlees J., Gioannini T.L., Weiss J., Chen W.H., Ernst R.K., Rossignol D.P., Gusovsky F., Blanco J.C., Vogel S.N. (2013) The TLR4 antagonist Eritoran protects mice from lethal influenza infection. Nature 497, 7450, 498–502.
[311] Shringarpure R., Davies K.J. (2002) Protein turnover by the proteasome in aging and disease. Free Radic Biol Med 32, 11, 1084-9.
[312] Silachev D.N., Isaev N.K., Pevzner I.B., Zorova L.D., Stelmashook E.V., Novikova S.V., Plotnikov E.Y., Skulachev V.P., Zorov D.B. (2012) The mitochondria-targeted antioxidants and remote kidney preconditioning ameliorate brain damage through kidney-to-brain cross-talk. PLoS One 7, 12, e51553.
[313] Sitte N., Merker K., Von Zglinicki T., Grune T., Davies K.J. (2000) Protein oxidation and degradation during cellular senescence of human BJ fibroblasts: part I-effects of proliferative senescence. FASEB J 14, 15, 2495-502.
[314] Sivan S.S., Van El B., Merkher Y., Schmelzer C.E., Zuurmond A.M., Heinz A., Wachtel E., Varga P.P., Lazary A., Brayda-Bruno M., Maroudas A. (2012) Longevity of elastin in human intervertebral disc as probed by the racemization of aspartic acid. Biochim Biophys Acta 1820, 10, 1671-7.
[315] Skulachev M.V., Antonenko Y.N., Anisimov V.N., Chernyak B.V., Cherepanov D.A., Chistyakov V.A., Egorov M.V., Kolosova N.G., Korshunova G.A., Lyamzaev K.G., Plotnikov E.Y., Roginsky V.A., Savchenko A.Y., Severina I.I., Severin F.F., Shkurat T.P., Tashlitsky V.N., Shidlovsky K.M., Vyssokikh M.Y., Zamyatnin A.A., Zorov D.B., Skulachev V.P. (2011) Mitochondrial-targeted plastoquinone derivatives. Effect on senescence and acute age-related pathologies. Curr Drug Targets 12, 6, 800–826.
[316] Skulachev V.P. (1988) Membrane bioenergetics, Springer-Verlag. Berlin; New York.
[317] Skulachev V.P. (1991) Fatty acid circuit as a physiological mechanism of uncoupling of oxidative phosphorylation. FEBS Lett 294, 3, 158-62.
[318] Skulachev V.P. (1996) Role of uncoupled and non-coupled oxidations in maintenance of safely low levels of oxygen and its one-electron reductants. Q Rev Biophys 29, 2, 169–202.
[319] Skulachev V.P. (1996) Why are mitochondria involved in apoptosis? Permeability transition pores and apoptosis as selective mechanisms to eliminate superoxide-producing mitochondria and cell. FEBS Lett 397, 1, 7-10.
[320] Skulachev V.P. (1998) Uncoupling: new approaches to an old problem of bioenergetics. Biochim Biophys Acta